This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for LeMaitre Vascular's Median PS Value or its related term are showing as below:
LMAT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.11 Med: 2.09 Max: 3.48
Current: 1.28
During the past 13 years, the highest Price to Median PS Value of LeMaitre Vascular was 3.48. The lowest was 1.11. And the median was 2.09.
LMAT's Price-to-Median-PS-Value is ranked worse than 78.91% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 0.78
vs LMAT: 1.28
LeMaitre Vascular Median PS Value Historical Data
The historical data trend for LeMaitre Vascular's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LeMaitre Vascular's Median PS Value
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.9089.
LeMaitre Vascular's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.631.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (NAS:LMAT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
LeMaitre Vascular's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
65.46
/
51.00
=
1.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular Median PS Value Related Terms
Thank you for viewing the detailed overview of LeMaitre Vascular's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
LeMaitre Vascular (LeMaitre Vascular) Business Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LMAT has been successfully added to your 